OLR1 and coronary artery disorder: Despite the still unclear function of sLOX-1 in the circulation there is growing evidence that this receptor fragment might be used as clinical biomarker for the diagnosis of vascular disease including coronary artery disease (CAD), acute coronary syndrome (ACS), ischemic stroke and acute aortic dissection (AAD).